ERBB2 and breast cancer: We applied scATOMIC to the training-independent validation dataset containing 38 tumours spanning ER + , HER2 + , and TN breast cancer, and 2 HER2 + /ER + double positive tumours, a class not represented in the current reference of scATOMIC’s breast mode due to a lack of data.